FDA Guidance on Covariate Adjustments: What Non-Statisticians Need to Know

In May 2023 the FDA issued a final guidance on adjusting for covariates in the statistical analysis of randomized clinical trials. Non-statistical team members should read this summary of the general considerations section found in the FDA’s guidance to better understand and support covariate adjustments applied in clinical trials.